.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.

.
the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid.
.
mayo clinic: "migraine: diagnosis & treatment," "monoclonal antibody drugs for cancer: how they work."
.